Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches.

FDA recall notice · announced May 16, 2018 · Maya Distribution

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches.

Reason for recall

Samples collected by public health officials found the presence of Salmonella.

Notes

Distribution: Recalled product was distributed to retail stores in AZ, IA, ID, IL, KS, MI, UT, and WY.
Lot/code information: unknown
Quantity: Unknown
Status: Terminated
Products in this recall event:
- Dragon Bali Kratom Powder: 60g Bottle. Dragon Bali Kratom Capsules in bottles:200 ct 500mg, 80 ct x 500, 40 ct x 500mg and 20 ct x 500 mg pouch. (F-1461-2018)
- Dragon Malaysian Kratom Powder: 150 g bottle. Dragon Malaysian Kratom: 200-, 80-, and 40-ct x 500mg capsules in bottles. Dragon Malaysian Kratom: 20-ct x 500 mg capsules in pouches. (F-1459-2018)
- Dragon Maeng Da Kratom Powder: 60 g and 150 g bottle. Dragon Maeng Da Kratom: 200-, 80-, and 40-ct x 500mg capsules in bottles. (F-1460-2018)
- Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches. (F-1458-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.